Pathology of clinical and preclinical Alzheimer's disease (Q45353164)

13 December 2017

Pathology of clinical and preclinical Alzheimer's disease (English)

1 reference

13 December 2017

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Johannes Attems

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Christine von Arnim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

W Sue T Griffin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Haruyasu Yamaguchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Robert E Mrak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ajeet Rijal Upadhaya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

1 November 2013

1 reference

European Archives of Psychiatry and Clinical Neuroscience

13 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

263 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

S137-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077890%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00406-013-0449-5

31 May 2020

exact match

0 references

cites work

Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Correlations between cortical and subcortical tau pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

High-molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Sequence of Abeta-protein deposition in the human medial temporal lobe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0449-5

Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24077890

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinicopathologic significance of granulovacuolar degeneration in Alzheimer's disease.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24077890

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The pathogenesis of senile plaques

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24077890